Jason Russell Chambers serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they oversee executive responsibilities. Since joining the company, Jason Russell Chambers has executed 55 insider transactions totaling $341.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 11, 2008 involved purchasing 200 shares valued at $920.
Jason Russell Chambers currently holds 149,061 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Russell Chambers has been a net buyer of HRT stock. They have purchased $296.9K and sold $44.2K worth of shares.
Jason Russell Chambers's most recent insider trade was on Sep 11, 2008, when they purchased 200 shares at $4.60 per share.
Get notified when new Form 4 filings are submitted
| $4.55 |
| Discretionary |
| Aug 21, 2007 | HRT | $19.4K | Purchase | 2,100 | $9.25 | Discretionary |
| Aug 16, 2007 | HRT | $26.8K | Purchase | 2,900 | $9.24 | Discretionary |
| Nov 29, 2006 | HRT | $240.8K | Disposition | 10,000 | $24.08 | Discretionary |